NASDAQ
Precision BioSciences, Inc. (DTIL) has a free cash flow growth of -5.95% as of Friday, May 29, 2026. This represents a 155.34% decrease compared to its 12-month average of 10.74%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.